Global Molecular Diagnostics and NAT Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13438788

Publishing Date : 10-May-2019

No. of pages : 98

PRICE
3900
7800


  • Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
    At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
    In 2018, the global Molecular Diagnostics and NAT market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Molecular Diagnostics and NAT status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics and NAT development in United States, Europe and China.

    The key players covered in this study
    Roche
    Abbott
    BD
    Biomerieux
    Qiagen
    Thermo Fisher Scientific
    Agilent
    GenMark
    Siemens Healthcare
    AutoGenomics

    Market segment by Type, the product can be split into
    Amplification Technologies
    Amplified Gene Detection Technologies
    DNA And Oligonucleotide Microarrays
    Gene Sequencing

    Market segment by Application, split into
    Hospitals and Clinics
    Research Institutes
    Diagnostic Centers

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Molecular Diagnostics and NAT status, future forecast, growth opportunity, key market and key players.
    To present the Molecular Diagnostics and NAT development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Molecular Diagnostics and NAT are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.